Literature DB >> 1825438

Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.

M Takatani1, N Maezaki, Y Imura, Z Terashita, K Nishikawa, S Tsushima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1825438

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  2 in total

1.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

2.  Role of platelet activating factor in pathogenesis of acute pancreatitis in rats.

Authors:  S J Konturek; A Dembinski; P J Konturek; Z Warzecha; J Jaworek; P Gustaw; R Tomaszewska; J Stachura
Journal:  Gut       Date:  1992-09       Impact factor: 23.059
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.